Efficient arrhythmia diagnosis with lower operating costs.
Technology recommended by your patients.
Satisfaction guaranteed: patients complete the exam and recommend your service.
The best experience
ZERO maintenance
NPS 95.9
Loved by doctors and highly rated by patients.
Average rating of 4.7/5 for ease of use ⁸ and reliability.
Heart monitor and event recorder in a single device.
Better clinical results
99% accuracy in identifying atrial fibrillation or flutter. 7
Long-term examinations with a 1.6 times higher diagnosis rate for severe arrhythmias. 4
Analysis supported by validated algorithmic models. 7
More practical operation
No cable, battery or SD card management.
Signal qualification at the time of installation via telemetry.
Online transmission of exams, speeding up analysis.
Greater patient satisfaction
4 times more comfortable than conventional Holter monitoring. 7
100% more comfort for daily activities.
Covered by health insurance for 24-hour examinations in Brazil. 11
An easier and more qualified single solution for cardiac monitoring, expanding your range of services
Diagnostic analysis flow aided by validated algorithmic models.
It identifies anomalies that are imperceptible to the human eye.10
The validated algorithmic models are intended to assist doctors by highlighting potential arrhythmic events. The results are designed for interpretation and confirmation by qualified healthcare professionals and do not replace medical judgment.
Real-time capture and transmission via Bluetooth
Rapid analysis of large volumes of data 10
Identification of arrhythmia patterns 10
99% accuracy in identifying atrial fibrillation (AF) 7
ZERO initial investment
Technical support and training included in the subscription
Replacing the device, if necessary
Devices and charger at no extra cost
Payment per exam performed
1 in 10 clinics already use QuoreOne in Brazil
Today I can say that at Lapacor we have the most modern and comfortable Holter on the market. In 3 months of operation, we have increased our Holter test capacity by 40% and reduced installation time by 20%.
Cristina Pedrassi - Administrator at Lapacor
Why are so many clinics and hospitals switching to QuoreOne?
100% reduction in maintenance costs.
Reducing the time between test prescription and report from weeks to days.
Cloud-based exam analysis platform, enabling agile report generation.
Zero initial investment: subscription model that preserves working capital.
Greater patient satisfaction: NPS of 95.9.
Includes technical support and training for the entire team.
A 40% increase in examination capacity with a 20% reduction in installation time, according to our customers.
Recurring revenue: contract renewal rate of over 90%.
Immediate scalability: add devices as your demand grows.
References
1. Worldometer, Current World Population, Available at: [https://www.worldometers.info/world-population/], Accessed on: April 25, 2025
2. Karamitanha F., et al, Difference Between Various Countries in Mortality and Incidence Rate of the Atrial Fibrillation Based on Human Development Index in Worldwide: Data From Global Burden of Disease 2010-2019, Current Problems in Cardiology Volume 48, Issue 1, January 2023
3. Van Gelder I. C, et al, 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal (2024) 00, 1-101, https://doi.org/10.1093/eurheartj/ehae176 and Risks, 1990-2022100000.
4.Known S., et al, Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study, J Med Internet Res. 2022 May; 24(5): e37970. Published online May 9, 2022. doi: 10.2196/37970: 10.2196/37970.
5. Kim J. Y., et al, The efficacy of detecting arrhythmia is higher with 7-day continuous electrocardiographic patch monitoring than with 24-h Holter monitoring, Journal of Arrhythmia, Received: January 3, 2023 | Revised: April 13, 2023 | Accepted: April 20, 2023, DOI: 10.1002/joa3.12865.
6. Cadastro Nacional de Estabelecimentos de Saúde (CNES), Consulta Estabelecimentos, Nome com "COR" ou "CARDIO", mediana dos estabelecimentos, Available at: [https://cnes.datasus.gov.br/], accessed on 02May2025.
7. Hospital Israelita Albert Einstein, A Comparative study of an innovative 3-lead wireless water resistant Holter system and a conventional Holter system, Available at: [https://clinicaltrials.gov/study/NCT04723355?term=Quoretech&rank=1]; Accessed on: 25April2025
8. Data on file, Quoretech July/21
9. Yenikomshian M., et al, Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review, Curr Med Res Opin. 2019 Oct;35(10):1659-1670. doi: 10.1080/03007995.2019.1610370. Epub 2019 May 28.
10. Leclercq C., et al, Wearables, telemedicine and artificial intelligence in arrhythmias and heart failure: Proceedings of the Cardiovascular Roundtable of the European Society of Cardiology, EP Europace, Volume 24, Issue 9, September 2022, Pages 1372-1383, https://doi.org/10.1093/europace/euac05
11. ROL_ANS, Available at: [https://www.ans.gov.br/ROL-web/], Accessed on: 25April2025
12. SOBRAC, A vida de um portador de arrritmia cardíaca, Available at: [https://sobrac.org/publico-geral/sdrfvesfvs/], Accessed on: April 25, 2025
13. ANS, TISS Data Panel, Procedures 2024, Available at: [https://app.powerbi.com/view?r=eyJrIjoiZGVjMDI2NjItNTUzMS00OWJkLTgwNjMtOTJmNTVlYzYwMTg0IiwidCI6IjlkYmE0ODBjLTRmYTctNDJmNC1iYmEzLTBmYjEzNzVmYmU1ZiJ9], Accessed on: April 25, 2025
14. DATASUS, AMBULATORY PRODUCTION OF THE SUS - BRAZIL - BY PLACE OF CARE, HOLTER, Available at: [http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sia/cnv/qabr.def], Accessed on: 25April2025
The validated algorithmic models are intended to assist doctors by highlighting potential arrhythmic events. The results are designed for interpretation and confirmation by qualified healthcare professionals and do not replace medical judgment.
